Published in Brain on January 19, 2005
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Brain biopsy in neurologic decline of unknown etiology. Hum Pathol (2014) 1.97
Cerebral amyloid angiopathy: a systematic review. J Clin Neurol (2011) 1.77
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther (2009) 1.57
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol (2009) 1.57
Multimodality Review of Amyloid-related Diseases of the Central Nervous System. Radiographics (2016) 1.53
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol (2009) 1.16
Cerebral amyloid angiopathy: emerging concepts. J Stroke (2015) 1.14
Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology (2013) 1.09
Eosinophilic vasculitis in an isolated central nervous system distribution. BMJ Case Rep (2009) 1.06
Central nervous system vasculitis. Semin Immunopathol (2009) 1.00
Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction: case report and review of the literature. J Neuroinflammation (2011) 1.00
Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome. Neuroradiology (2014) 0.96
Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment. J Neuroinflammation (2010) 0.92
The spectrum of CNS vasculitis in children and adults. Nat Rev Rheumatol (2011) 0.84
An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients. Medicine (Baltimore) (2015) 0.83
Focused microarray analysis of peripheral mononuclear blood cells from Churg-Strauss syndrome patients. DNA Res (2008) 0.83
[Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the Network Lymphomas and Lymphomatoid Lesions in the Nervous System]. Pathologe (2013) 0.80
Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer's disease. Front Neurol (2012) 0.79
Cerebral amyloid angiopathy related vasculitis: successful treatment with azathioprine. J Neurol (2010) 0.79
Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation. J Neuroinflammation (2013) 0.78
Immune mediated diseases and immune modulation in the neurocritical care unit. Neurotherapeutics (2012) 0.78
Eosinophilic vasculitis in an isolated central nervous system distribution. J Neurol Neurosurg Psychiatry (2006) 0.78
Cerebral amyloid angiopathy revealed by rapidly progressing leptomeningeal lesions. J Neurol (2014) 0.76
Reduction of microbleeds by immunosuppression in a patient with Aβ-related vascular inflammation. Neurol Neuroimmunol Neuroinflamm (2015) 0.75
Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series. Neurocase (2011) 0.75
A 61-Year-Old Woman With Headaches and Aphasia. Neurohospitalist (2015) 0.75
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience. Medicine (Baltimore) (2016) 0.75
Association of angiitis of central nervous system, cerebral amyloid angiopathy, and Alzheimer's disease: report of an autopsy case. Vasc Health Risk Manag (2008) 0.75
Amyloid β-Related Central Nervous System Angiitis Presenting With an Isolated Seizure. Neurohospitalist (2014) 0.75
Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure. Neurol Clin Pract (2017) 0.75
Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation. Neurology (2016) 0.75
Amyloid β-Related Angiitis Causing Coma Responsive to Immunosuppression. Case Rep Pathol (2012) 0.75
Primary angiitis of the central nervous system presenting with subacute and fatal course of disease: a case report. BMC Neurol (2005) 0.75
Idiopathic hypereosinophilic syndrome: a new cause of vasculitis of the central nervous system. J Neurol (2015) 0.75
Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy. J Alzheimers Dis (2017) 0.75
Evidence for inflammation in Fabry's disease? Headache and muscle involvement responding to corticosteroid and methotrexate treatment. J Neurol (2017) 0.75
Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation. J Neurol (2016) 0.75
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet (2008) 8.51
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One (2008) 5.86
A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02
Clinicopathological correlates in frontotemporal dementia. Ann Neurol (2004) 4.38
Clinical and pathological characterization of progressive aphasia. Ann Neurol (2006) 4.37
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report. J Neurosurg Spine (2014) 3.38
The pathological basis of semantic dementia. Brain (2005) 2.96
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol (2008) 2.90
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ (2013) 2.74
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A (2009) 2.72
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev (2009) 2.58
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA (2012) 2.49
Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol (2008) 2.26
Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis (2002) 2.20
Papillary tumor of the pineal region. Am J Surg Pathol (2003) 2.13
Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med (2002) 1.86
Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain (2008) 1.84
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol (2005) 1.77
Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ (2009) 1.75
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
Nedd4 controls animal growth by regulating IGF-1 signaling. Sci Signal (2008) 1.67
CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity. Clin Infect Dis (2013) 1.60
Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimers Dis (2009) 1.53
Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain (2012) 1.52
Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis. Brain Pathol (2011) 1.52
High grade glioma: imaging combined with pathological grade defines management and predicts prognosis. Radiother Oncol (2007) 1.52
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med (2005) 1.49
A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol (2012) 1.44
Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol (2005) 1.43
Aβ-degrading enzymes: potential for treatment of Alzheimer disease. J Neuropathol Exp Neurol (2011) 1.42
Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer. J Clin Oncol (2007) 1.41
Oculopharyngodistal myopathy--a possible association with cardiomyopathy. Neuromuscul Disord (2010) 1.40
Trends in suicide by carbon monoxide inhalation in King County, Washington: 1996-2009. J Forensic Sci (2011) 1.38
The human perirhinal cortex and semantic memory. Eur J Neurosci (2004) 1.38
Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nat Genet (2007) 1.38
Intraductal papillary mucinous adenoma that arises from pancreatic heterotopia within a meckel diverticulum. Arch Pathol Lab Med (2005) 1.35
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol (2008) 1.33
Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). Brain (2005) 1.33
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol (2006) 1.31
Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain (2009) 1.31
Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol (2002) 1.30
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice. Eur J Cancer (2008) 1.30
Is the pathology of corticobasal syndrome predictable in life? Mov Disord (2009) 1.29
Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ (2006) 1.28
Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer (2005) 1.27
Toward an understanding of dural ectasia: a light microscopy study in a murine model of Marfan syndrome. Spine (Phila Pa 1976) (2005) 1.27
Angiotensins in Alzheimer's disease - friend or foe? Trends Neurosci (2009) 1.25
Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability. Acta Neuropathol (2014) 1.24
Lab-on-a-chip devices as an emerging platform for stem cell biology. Lab Chip (2010) 1.20
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol (2009) 1.16
Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res (2009) 1.15
Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol (2007) 1.15
Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol (2004) 1.14
Distribution and expression of picalm in Alzheimer disease. J Neuropathol Exp Neurol (2010) 1.13
Pathogenic mitochondrial tRNA point mutations: nine novel mutations affirm their importance as a cause of mitochondrial disease. Hum Mutat (2013) 1.12
Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia. Biol Reprod (2006) 1.12
4-monochlorobiphenyl (PCB3) induces mutations in the livers of transgenic Fisher 344 rats. Carcinogenesis (2006) 1.12
Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma. Mol Cancer (2007) 1.09
Epilepsy surgery for refractory epilepsy due to encephalocele: a case report and review of the literature. Epileptic Disord (2010) 1.09
Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation (2007) 1.08
Brain damage after heat stroke. J Neuropathol Exp Neurol (2005) 1.07
The pathogenesis of neonatal post-hemorrhagic hydrocephalus. Brain Pathol (2004) 1.06
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat (2004) 1.06
Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. Biochim Biophys Acta (2012) 1.05
Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol (2009) 1.05
Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta. Am J Pathol (2009) 1.05
Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay. J Neurosci Methods (2004) 1.04
Mice defective in Trpm6 show embryonic mortality and neural tube defects. Hum Mol Genet (2009) 1.04
Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing. Brain (2005) 1.04
Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis. Cancer (2009) 1.03
Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathol (2010) 1.03
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization. Brain (2013) 1.03
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis (2012) 1.02
Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Mol Cell Biol (2009) 1.02
Cathepsin S expression: An independent prognostic factor in glioblastoma tumours--A pilot study. Int J Cancer (2006) 1.02
Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy. J Nucl Med (2007) 1.01
Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease. Acta Neuropathol (2010) 1.01
Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res (2009) 1.00
Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain (2003) 1.00
Multifocal necrotizing leukoencephalopathy in septic shock. Crit Care Med (2002) 0.99
Memory loss resulting from fornix and septal damage: impaired supra-span recall but preserved recognition over a 24-hour delay. Neuropsychology (2008) 0.99
Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging (2005) 0.99
Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β. J Alzheimers Dis (2012) 0.98
A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis. Proc Natl Acad Sci U S A (2010) 0.98
Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia. Biol Psychiatry (2007) 0.98
Elevated myeloperoxidase activity in white matter in multiple sclerosis. Neurosci Lett (2008) 0.98
Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide. J Nucl Med (2009) 0.98
Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates. J Neurosci Methods (2008) 0.97
CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PLoS One (2012) 0.96
A "neurosurgical crisis" of sickle cell disease. J Neurosurg Pediatr (2009) 0.95
Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study. J Pathol (2010) 0.94